Stockscreener 앱 받기
3.75
3.59%
0.13
시간 외 거래:
3.75
전일 마감가:
$3.62
열려 있는:
$3.62
하루 거래량:
34,472
Relative Volume:
0.46
시가총액:
$250.08M
수익:
$64.49M
순이익/손실:
$-71.40M
주가수익비율:
-3.4404
EPS:
-1.09
순현금흐름:
$-52.00M
1주 성능:
+0.00%
1개월 성능:
+28.42%
6개월 성능:
+20.19%
1년 성능:
-20.38%
1일 변동 폭
$3.61
$3.75
1주일 범위
$3.3556
$3.75
52주 변동 폭
$2.58
$4.92
Sophia Genetics Sa Stock (SOPH) Company Profile
SOPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
3.75 | 250.58M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
276.46 | 46.02B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
60.65 | 10.32B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
100.12 | 8.40B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
61.60 | 11.28B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
37.06 | 6.51B | 906.14M | -52.62M | 89.62M | -0.3621 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 개시 | Craig Hallum | Buy |
| 2024-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-27 | 개시 | Guggenheim | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-03 | 개시 | BTIG Research | Buy |
| 2022-11-23 | 개시 | Credit Suisse | Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-17 | 개시 | Cowen | Outperform |
| 2021-08-17 | 개시 | Credit Suisse | Outperform |
| 2021-08-17 | 개시 | JP Morgan | Overweight |
| 2021-08-17 | 개시 | Morgan Stanley | Overweight |
모두보기
Sophia Genetics Sa 주식(SOPH)의 최신 뉴스
SPICE(spice 3) Latest NewsTargeted 200 Percent Gain - Newser
Why SOPHiA GENETICS SA stock attracts strong analyst attentionReal Chart Play - Newser
How CuriosityStream Inc. stock performs during market volatilityChart Breakout Alert - Newser
How Falcon s Beyond Global Inc. stock performs during market volatilityFree Best Performing Stock Suggestions - Newser
What makes SOPHiA GENETICS SA stock price move sharplyProven Trading Plan - Newser
Bradstreet Holdings Inc. stock attracts strong analyst attentionCapital Growth Picks - Newser
What makes IT Tech Packaging Inc. stock price move sharplyFree Long-Term Wealth Growth Plan - Newser
How SOPHiA GENETICS SA stock performs during market volatilityFree Stock Trading Community - Newser
When BANL stock expected to show significant growthIs STRL stock a good long term investment optionWeekly Double Return List - Newser
What makes SEZL stock price move sharplyFree Access to Investment Community - Newser
Turning Proof Into Power: Bioz Partners With SOPHiA GENETICS to Enhance Scientific Transparency via Custom Integration - Yahoo Finance
RELI cuts debt 50% after $5M Fortman sale; saves $1.8M annually | SOPH SEC FilingForm S-8 - Stock Titan
Revenues Tell The Story For SOPHiA GENETICS SA (NASDAQ:SOPH) As Its Stock Soars 29% - simplywall.st
SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Up 8.7% – What’s Next? - Defense World
LOOP(loop x network) Price TodayDaily Volume Leaders - Newser
SOPHiA GENETICS Announces Key Approvals at 2025 Annual General Meeting - TipRanks
Precision Medicine Software Market Future Trends and Scope - openPR.com
Radiomics Market Key Players AnalysisRadiomics.io - openPR.com
SOPHiA GENETICS SA (NASDAQ:SOPH) Shares Sold by Squarepoint Ops LLC - Defense World
Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today? - sharewise
Bioinformatics Market Overview & Insights by 2032 - newstrail.com
Millennium Management LLC Increases Position in SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
Dimensional Fund Advisors LP Has $68,000 Stock Holdings in SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World
Top Market Trend Impacting AI In Bioinformatics Development in the Coming Years: Bionl.AI Platform Revoluti... - WhaTech
After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order? - Yahoo Finance
SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2025 Earnings Call Transcript - Insider Monkey
SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates - MSN
SOPHiA GENETICS Q1 2025 Earnings Call Highlights - TipRanks
SOPHiA GENETICS First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
SOPHiA GENETICS SA 2025 Q1ResultsEarnings Call Presentation (NASDAQ:SOPH) - Seeking Alpha
SOPHiA GENETICS sets date for annual shareholder meeting - Investing.com Australia
SOPHiA GENETICS sets date for annual shareholder meeting By Investing.com - Investing.com South Africa
Sophia Genetics SA (SOPH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Improved ... By GuruFocus - Investing.com Canada
SOPHiA GENETICS Reports Strong Q1 2025 Growth - TipRanks
SOPHiA GENETICS Q1 2025 Earnings Call Transcript - MarketBeat
SOPHiA GENETICS Reports Q1 2025 Financial Results - TipRanks
SOPH Hits Revenue and Margin Milestones in Q1 2024 | SOPH Stock News - GuruFocus
SOPHiA GENETICS Reports First Quarter 2025 Results - Quantisnow
Earnings To Watch: Sophia Genetics SA (SOPH) Reports Q1 2025 Result - Yahoo Finance
Sophia Genetics SA expected to post a loss of 25 cents a shareEarnings Preview - TradingView
Promising Penny Stocks To Consider In April 2025 - simplywall.st
Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings? - The Globe and Mail
SOPHia Genetics expands testing partnership with AstraZeneca - MSN
SOPHiA Genetics (SOPH) Expands Liquid Biopsy Collaboration with AstraZeneca - GuruFocus
SOPHiA GENETICS Expands Global Collaboration With AstraZeneca To Advance Liquid Biopsy Testing - Nasdaq
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR – Company AnnouncementFT.com - Financial Times
SOPHiA GENETICS SA's (NASDAQ:SOPH) market cap touched US$204m last week, benefiting both individual investors who own 51% as well as institutions - simplywall.st
The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS - Yahoo Finance
SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025 - marketscreener.com
Sophia Genetics Sa (SOPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.25%
0.96%
자본화:
|
볼륨(24시간):